Sri Krishna Sai Bio Products Lim Ited Profile
Key Indicators
- Authorised Capital ₹ 9.00 M
as on 18-06-2024
- Paid Up Capital ₹ 7.21 M
as on 18-06-2024
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.50 Cr
as on 18-06-2024
- Revenue 220.78%
(FY 2022)
- Profit 59.75%
(FY 2022)
- Ebitda -9.12%
(FY 2022)
- Net Worth 16.96%
(FY 2022)
- Total Assets 19.30%
(FY 2022)
About Sri Krishna Sai Bio Products Lim Ited
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.00 M and a paid-up capital of Rs 7.21 M.
The company currently has active open charges totaling ₹1.50 Cr.
Potluri Indira and Ravi Potluri serve as directors at the Company.
- CIN/LLPIN
U24232AP2012PTC080356
- Company No.
080356
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Apr 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Gudivada, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sri Krishna Sai Bio Products Private Lim Ited offer?
Sri Krishna Sai Bio Products Private Lim Ited offers a wide range of products and services, including FRP Lining, PU & Powder Coatings, Epoxy Paints and Coatings, Flavours & Aromatics, Food Enzymes, Fertilizers and Soil Additives, Fertilizer.
Who are the key members and board of directors at Sri Krishna Sai Bio Products Lim Ited?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravi Potluri  | Managing Director | 17-Apr-2012 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Potluri Indira | Director | 21-May-2013 | Current |
Financial Performance of Sri Krishna Sai Bio Products Lim Ited.
Sri Krishna Sai Bio Products Private Lim Ited, for the financial year ended 2022, experienced significant growth in revenue, with a 220.78% increase. The company also saw a substantial improvement in profitability, with a 59.75% increase in profit. The company's net worth Soared by an impressive increase of 16.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sri Krishna Sai Bio Products Lim Ited?
In 2022, Sri Krishna Sai Bio Products Lim Ited had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Mar 2013 | ₹1.50 Cr | Open |
How Many Employees Work at Sri Krishna Sai Bio Products Lim Ited?
Unlock and access historical data on people associated with Sri Krishna Sai Bio Products Lim Ited, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Krishna Sai Bio Products Lim Ited, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Krishna Sai Bio Products Lim Ited's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
